Abstract Number: 2019 • 2012 ACR/ARHP Annual Meeting
A Novel MRI Scoring System for the Evaluation of Early-Stage Disease Activity of the Wrist in Juvenile Idiopathic Arthritis
Background/Purpose: Evidence that early therapeutic intervention prevents structural damage in juvenile idiopathic arthritis (JIA) patients requires focus on early-stage disease activity scores. Most outcome measures…Abstract Number: 1979 • 2012 ACR/ARHP Annual Meeting
Care Gap in the Treatment of Patients with High Risk for Fractures in a Single Canadian Academic Center
Background/Purpose: A number of clinical prediction tools are available to stratify patients into low, moderate and high risk for fractures in future. These tools are…Abstract Number: 1980 • 2012 ACR/ARHP Annual Meeting
Intermittent Nitrate Use and Risk of Hip Fracture
Background/Purpose: Nitrates are commonly used anti-anginal medications which have also been found to promote bone formation and decreases bone resorption. Intermittent nitrate use has been…Abstract Number: 1981 • 2012 ACR/ARHP Annual Meeting
Low Body Mass Index, Medication Use and Social Factors Such As Smoking but Not Secondary Medical Disorders or Older Age May Be More Prevalent in Males with Low Bone Mineral Density
Background/Purpose: Osteoporosis (OP) in Males is prevalent and frequently under-recognized. There are a number of known demographic factors such as age, race and BMI as…Abstract Number: 1982 • 2012 ACR/ARHP Annual Meeting
Five Years of Treatment to Target in Early Active Rheumatoid Arthritis: Prevalence and Predictors of Vertebral Fractures
Background/Purpose: Vertebral fractures (VFs) are more common in patients with rheumatoid arthritis (RA) compared to the general population. It is suggested that an appropriate control…Abstract Number: 1983 • 2012 ACR/ARHP Annual Meeting
Comparative Risk of Fracture in Men and Women with Human Immunodeficiency Virus
Background/Purpose: A growing body of evidence suggests that HIV-positive patients have an increased risk of osteoporosis compared to HIV-negative patients, with some studies suggesting a…Abstract Number: 1985 • 2012 ACR/ARHP Annual Meeting
The Effect of Calcium and Vitamin D On Bone Loss in an Epileptic Population
Background/Purpose: Accelerated rate of bone loss leading to osteopenia and osteoporosis is a well recognized adverse effect of long term anticonvulsant use, particularly phenytoin,…Abstract Number: 1986 • 2012 ACR/ARHP Annual Meeting
Impaired Endothelial Function in Post-Menopausal Women with Osteoporosis
Background/Purpose: Although traditionally viewed as separate disease entities that increase in prevalence with aging, accumulating evidence indicates that similar pathophysiological mechanisms may underlie cardiovascular disease…Abstract Number: 1987 • 2012 ACR/ARHP Annual Meeting
A Comparison of Unilateral and Bilateral Hip BMD
Background/Purpose: The utility of bilateral hip dual energy x-ray absorptiometry scanning for identifying low bone mineral density has been a cause of debate. Intraperson differences…Abstract Number: 1988 • 2012 ACR/ARHP Annual Meeting
Zoledronate Efficacy and Safety in Active Paget’s Disease Long-Term Follow-up and Retreatment in Clinical Practice
Background/Purpose: Bisphosphonates are first line therapy in the treatment of Paget's disease (PD). Zoledronate, a third generation bisphosphonate, has showed high efficacy in the inhibition…Abstract Number: 1989 • 2012 ACR/ARHP Annual Meeting
Risk Factors for Vertebral Fractures in Patients with Rheumatoid Arthritis – the Tomorrow Study –
Background/Purpose: Rheumatoid arthritis (RA) is one of the causes for secondary osteoporosis. Osteoporosis as a multifactorial disease might be derived from comorbidity itself, poorer physical…Abstract Number: 1990 • 2012 ACR/ARHP Annual Meeting
Risk of Falling Is Equivalent Between Patients with Rheumatoid Arthritis and Healthy Individuals – the Tomorrow Study-
Background/Purpose: Patients with rheumatoid arthritis (RA) who have muscle weakness and stiff or painful joints might be at increased risk of falling. The present study…Abstract Number: 1991 • 2012 ACR/ARHP Annual Meeting
Effects of Odanacatib On the Distal Radius and Tibia in Postmenopausal Women: Improvements in Cortical Geometry and Estimated Bone Strength
Background/Purpose: The cathepsin K inhibitor odanacatib (ODN), a novel antiresorptive that preserves bone formation, is currently in phase 3 development for postmenopausal osteoporosis. In a…Abstract Number: 1992 • 2012 ACR/ARHP Annual Meeting
Anti-TNF Therapies Improve Bone Mineral Density At the Lumbar Spine of RA Patients by Decreasing Disease Activity and Suppressing Serum RANKL Levels
Background/Purpose: Generalized bone loss (osteoporosis or osteopenia) is more common in patients with rheumatoid arthritis (RA) than in the general population. Recent studies suggest that…Abstract Number: 1993 • 2012 ACR/ARHP Annual Meeting
Contribution of Lifestyle Factors to Healthy-Adherer Bias in Prevalent Users of Osteoporotic Drugs
Background/Purpose: Adherence to drug therapy may be a surrogate marker for overall healthy behaviors leading to healthy-adherer bias in epidemiologic studies. This might be particularly…
ACR Meeting Abstracts